RAPT Therapeutics, Inc. (RAPT) Share-based Payment Arrangement, Expense USD 2018 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: RAPT Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2024.
RAPT Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $5.4 M, a 31.9% increase year-over-year.
RAPT Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $18.4 M, a 45.3% increase year-over-year.
RAPT Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $17.1 M, a 51.7% increase from 2022.
RAPT Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.3 M, a 13.2% increase from 2021.
RAPT Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $9.95 M, a 14.6% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$18.4 M	$5.4 M	+$1.3 M	+31.9%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$17.1 M	$4.43 M	+$1.4 M	+46.4%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-07
Q3 2023	$15.7 M	$4.33 M	+$1.46 M	+51.1%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$14.2 M	$4.24 M	+$1.57 M	+58.6%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$12.7 M	$4.09 M	+$1.39 M	+51.5%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	$11.3 M	$3.03 M	+$653 K	+27.5%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-07
Q3 2022	$10.6 M	$2.87 M	+$860 K	+42.9%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	$9.75 M	$2.67 M	-$216 K	-7.48%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-11
Q1 2022	$9.97 M	$2.7 M	+$15 K	+0.56%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	$9.95 M	$2.37 M	-$186 K	-7.27%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-14
Q3 2021	$10.1 M	$2.01 M	$0	0%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021	$10.1 M	$2.89 M	+$853 K	+41.9%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	$9.29 M	$2.69 M	+$599 K	+28.7%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-11
Q4 2020	$8.69 M	$2.56 M	+$1.66 M	+185%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-10
Q3 2020	$7.02 M	$2.01 M	+$1.57 M	+365%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	$5.45 M	$2.04 M	+$1.69 M	+486%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-11
Q1 2020	$3.76 M	$2.09 M	+$1.71 M	+454%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-11
Q4 2019	$2.05 M	$896 K			Oct 1, 2019	Dec 31, 2019	10-K	2021-03-11
Q3 2019		$431 K	+$136 K	+46.1%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-16
Q2 2019		$347 K			Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019		$377 K			Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-14
Q3 2018		$295 K			Jul 1, 2018	Sep 30, 2018	10-Q	2019-12-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.